TY - JOUR
T1 - Improving pathology and laboratory medicine in low-income and middle-income countries
T2 - roadmap to solutions
AU - Sayed, Shahin
AU - Cherniak, William
AU - Lawler, Mark
AU - Tan, Soo Yong
AU - El Sadr, Wafaa
AU - Wolf, Nicholas
AU - Silkensen, Shannon
AU - Brand, Nathan
AU - Looi, Lai Meng
AU - Pai, Sanjay A.
AU - Wilson, Michael L.
AU - Milner, Danny
AU - Flanigan, John
AU - Fleming, Kenneth A.
N1 - Publisher Copyright:
© 2018 Elsevier Ltd
PY - 2018/5/12
Y1 - 2018/5/12
N2 - Insufficient awareness of the centrality of pathology and laboratory medicine (PALM) to a functioning health-care system at policy and governmental level, with the resultant inadequate investment, has meant that efforts to enhance PALM in low-income and middle-income countries have been local, fragmented, and mostly unsustainable. Responding to the four major barriers in PALM service delivery that were identified in the first paper of this Series (workforce, infrastructure, education and training, and quality assurance), this second paper identifies potential solutions that can be applied in low-income and middle-income countries (LMICs). Increasing and retaining a quality PALM workforce requires access to mentorship and continuing professional development, task sharing, and the development of short-term visitor programmes. Opportunities to enhance the training of pathologists and allied PALM personnel by increasing and improving education provision must be explored and implemented. PALM infrastructure must be strengthened by addressing supply chain barriers, and ensuring laboratory information systems are in place. New technologies, including telepathology and point-of-care testing, can have a substantial role in PALM service delivery, if used appropriately. We emphasise the crucial importance of maintaining PALM quality and posit that all laboratories in LMICs should participate in quality assurance and accreditation programmes. A potential role for public-private partnerships in filling PALM services gaps should also be investigated. Finally, to deliver these solutions and ensure equitable access to essential services in LMICs, we propose a PALM package focused on these countries, integrated within a nationally tiered laboratory system, as part of an overarching national laboratory strategic plan.
AB - Insufficient awareness of the centrality of pathology and laboratory medicine (PALM) to a functioning health-care system at policy and governmental level, with the resultant inadequate investment, has meant that efforts to enhance PALM in low-income and middle-income countries have been local, fragmented, and mostly unsustainable. Responding to the four major barriers in PALM service delivery that were identified in the first paper of this Series (workforce, infrastructure, education and training, and quality assurance), this second paper identifies potential solutions that can be applied in low-income and middle-income countries (LMICs). Increasing and retaining a quality PALM workforce requires access to mentorship and continuing professional development, task sharing, and the development of short-term visitor programmes. Opportunities to enhance the training of pathologists and allied PALM personnel by increasing and improving education provision must be explored and implemented. PALM infrastructure must be strengthened by addressing supply chain barriers, and ensuring laboratory information systems are in place. New technologies, including telepathology and point-of-care testing, can have a substantial role in PALM service delivery, if used appropriately. We emphasise the crucial importance of maintaining PALM quality and posit that all laboratories in LMICs should participate in quality assurance and accreditation programmes. A potential role for public-private partnerships in filling PALM services gaps should also be investigated. Finally, to deliver these solutions and ensure equitable access to essential services in LMICs, we propose a PALM package focused on these countries, integrated within a nationally tiered laboratory system, as part of an overarching national laboratory strategic plan.
UR - http://www.scopus.com/inward/record.url?scp=85043526907&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(18)30459-8
DO - 10.1016/S0140-6736(18)30459-8
M3 - Review article
C2 - 29550027
AN - SCOPUS:85043526907
SN - 0140-6736
VL - 391
SP - 1939
EP - 1952
JO - The Lancet
JF - The Lancet
IS - 10133
ER -